Search
Search Results
-
Prediction of biochemical recurrence after laparoscopic radical prostatectomy
BackgroundRadical prostatectomy (RP) has been considered primary treatment for localized prostate cancer. Biochemical recurrence (BCR) occur...
-
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy
BackgroundIt remains unclear which patients with biochemical recurrence after prostatectomy are most suitable for salvage radiotherapy. We evaluated...
-
Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma
IntroductionAlthough papillary thyroid carcinoma (PTC) is thought to be the least aggressive thyroid cancer, it has a significant recurrence rate....
-
Predicting biochemical recurrence of prostate cancer with artificial intelligence
BackgroundThe first sign of metastatic prostate cancer after radical prostatectomy is rising PSA levels in the blood, termed biochemical recurrence....
-
Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence
BackgroundRadiotherapy (RT) after radical prostatectomy (RP) includes adjuvant radiotherapy (ART) and salvage radiotherapy (SRT), which can prevent...
-
PG I and PG II show unique value in diagnosing postoperative biochemical recurrence in patients with gastric cancer after total gastrectomy
ObjectiveTo investigate the potential of group I pepsinogen (PG I) and group II pepsinogen (PG II) as diagnostic markers for recurrence in gastric...
-
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients
Robot-assisted radical prostatectomy (RARP) has become one of the standard radical treatments for prostate cancer (PCa). A retrospective...
-
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer
PurposeMachine learning (ML) models presented an excellent performance in the prognosis prediction. However, the black box characteristic of ML...
-
Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy
BackgroundA predictive model for biochemical recurrence (BCR) of prostate cancer (PCa) after neoadjuvant androgen deprivation therapy (nADT) has not...
-
Perineural invasion as predictor of biochemical recurrence in prostate cancer following open radical prostatectomy: a single-center experience
PurposeTo explore the association between perineural invasion (PNI) and biochemical recurrence (BCR) in patients undergoing open radical...
-
PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?
PurposePSMA positron emission tomography (PET)/CT imaging and new systemic treatment strategies have been recently implemented in the routine care of...
-
Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics
PurposeThe objective was to assess the association between molecular imaging (mi) variables on [18F]DCFPyL-PET/CT with clinical and disease...
-
Index tumor location affected early biochemical recurrence after radical prostatectomy in patients with negative surgical margin: a retrospective study
BackgroundIndex tumors are the most aggressive tumors of the prostate. However, their clinical significance remains unclear. This study aimed to...
-
Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy
PurposeBiochemical recurrence (BCR) following radical prostatectomy (RP) is a significant concern for patients with prostate cancer. Reliable...
-
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
PurposeTo develop a CT-based radiomic signature to predict biochemical recurrence (BCR) in prostate cancer patients after sRT guided by...
-
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy
BackgroundRadiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate...
-
Management of Biochemical Recurrence of Prostate Cancer After Curative Treatment: A Focus on Older Patients
Following a treatment with curative intent, a biochemical recurrence may be diagnosed, often many years after the primary treatment. The consequences...
-
Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
BackgroundIn patients with prostate cancer (PCa), imaging with gastrin-releasing peptide receptor (GRPR) ligands is an alternative to PSMA-targeted...
-
Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy
BackgroundIn recent years, Genome-Wide Association Studies (GWAS) has identified risk variants related to complex diseases, but most genetic variants...
-
Strategy for PSA progression in patients undergoing salvage radiation for biochemical recurrence after radical prostatectomy
BackgroundThe treatment strategy for prostate-specific antigen (PSA) progression in patients who receive salvage radiation therapy (RT) for...
